{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:37:35Z","timestamp":1771580255980,"version":"3.50.1"},"reference-count":147,"publisher":"Elsevier","isbn-type":[{"value":"9780128046890","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/bs.acc.2015.12.004","type":"book-chapter","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T19:56:09Z","timestamp":1453406169000},"page":"63-102","source":"Crossref","is-referenced-by-count":25,"title":["Maternal Plasma DNA and RNA Sequencing for Prenatal Testing"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2015.12.004_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/scitranslmed.3001720","article-title":"Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus","volume":"2","author":"Lo","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1126\/scitranslmed.3004323","article-title":"Noninvasive whole-genome sequencing of a human fetus","volume":"4","author":"Kitzman","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pd.4583","article-title":"Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach","volume":"35","author":"Chitty","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0020","doi-asserted-by":"crossref","first-page":"F426","DOI":"10.1136\/archdischild-2013-304828","article-title":"Non-invasive prenatal diagnosis: progress and potential","volume":"99","author":"Daley","year":"2014","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/bs.acc.2015.12.004_bb0025","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00431-010-1253-0","article-title":"Clinical practice. The care of children with Down syndrome","volume":"169","author":"Weijerman","year":"2010","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/bs.acc.2015.12.004_bb0030","first-page":"1721","article-title":"Study of somatic chromosomes from 9 mongoloid children","volume":"248","author":"Lejeune","year":"1959","journal-title":"C. R. Hebd. Seances Acad. Sci."},{"key":"10.1016\/bs.acc.2015.12.004_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpeds.2007.09.045","article-title":"Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study","volume":"152","author":"Weijerman","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/bs.acc.2015.12.004_bb0040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jpeds.2013.06.013","article-title":"Current estimate of Down Syndrome population prevalence in the United States","volume":"163","author":"Presson","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/bs.acc.2015.12.004_bb0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2012.94","article-title":"Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening","volume":"21","author":"Loane","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"issue":"Spec. No","key":"10.1016\/bs.acc.2015.12.004_bb0050","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/hmg\/5.Supplement_1.1411","article-title":"Down syndrome genetics: unravelling a multifactorial disorder","volume":"5","author":"Hernandez","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/GRF.0000000000000013","article-title":"First trimester ultrasound assessment for fetal aneuploidy","volume":"57","author":"Hyett","year":"2014","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0060","first-page":"96","article-title":"Testing times: do new prenatal tests signal the end of Down syndrome?","volume":"126","author":"Cole","year":"2013","journal-title":"N. Z. Med. J."},{"key":"10.1016\/bs.acc.2015.12.004_bb0065","first-page":"CD000114","article-title":"Instruments for chorionic villus sampling for prenatal diagnosis","volume":"1","author":"Young","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/bs.acc.2015.12.004_bb0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<179::AID-AJMG15>3.0.CO;2-G","article-title":"European collaborative research on mosaicism in CVS (EUCROMIC)\u2014fetal and extrafetal cell lineages in 192 gestations with CVS mosaicism involving single autosomal trisomy","volume":"70","author":"Hahnemann","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0075","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/pd.3965","article-title":"Confined placental mosaicism at chorionic villous sampling: risk factors and pregnancy outcome","volume":"32","author":"Baffero","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.siny.2011.01.003","article-title":"Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies","volume":"16","author":"Faas","year":"2011","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000271995","article-title":"Update on procedure-related risks for prenatal diagnosis techniques","volume":"27","author":"Tabor","year":"2010","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/bs.acc.2015.12.004_bb0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.14636","article-title":"Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis","volume":"45","author":"Akolekar","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ogc.2015.01.011","article-title":"Genetics: update on prenatal screening and diagnosis","volume":"42","author":"Evans","year":"2015","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/bs.acc.2015.12.004_bb0100","first-page":"48","article-title":"Noninvasive prenatal testing: the future is now","volume":"6","author":"Norwitz","year":"2013","journal-title":"Rev. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/bs.acc.2015.12.004_bb0105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/pd.4608","article-title":"Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis","volume":"35","author":"Benn","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2006.02.004","article-title":"Georg Schmorl on trophoblasts in the maternal circulation","volume":"28","author":"Lapaire","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2015.12.004_bb0115","first-page":"241","article-title":"Les acides nucleiques du plasma sanguin chez l'homme","volume":"142","author":"Mandel","year":"1948","journal-title":"C. R. Acad. Sci. Paris"},{"key":"10.1016\/bs.acc.2015.12.004_bb0120","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(69)91642-0","article-title":"Practical and theoretical implications of fetal-maternal lymphocyte transfer","volume":"1","author":"Walknowska","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2015.12.004_bb0125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1073\/pnas.93.2.705","article-title":"Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum","volume":"93","author":"Bianchi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2015.12.004_bb0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2015.12.004_bb0135","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/301800","article-title":"Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis","volume":"62","author":"Lo","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0140","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(05)60534-X","article-title":"Detection of fetal RHD-specific sequences in maternal plasma","volume":"352","author":"Faas","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/bs.acc.2015.12.004_bb0145","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2015.12.004_bb0150","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood","volume":"105","author":"Fan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2015.12.004_bb0155","doi-asserted-by":"crossref","first-page":"c7401","DOI":"10.1136\/bmj.c7401","article-title":"Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study","volume":"342","author":"Chiu","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/bs.acc.2015.12.004_bb0160","doi-asserted-by":"crossref","first-page":"e21791","DOI":"10.1371\/journal.pone.0021791","article-title":"Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/bs.acc.2015.12.004_bb0165","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/pd.4139","article-title":"Aneuploidy screening: a position statement from a Committee on behalf of the Board of the International Society for Prenatal Diagnosis","volume":"33","author":"Benn","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/gim.2013.29","article-title":"ACMG statement on noninvasive prenatal screening for fetal aneuploidy","volume":"15","author":"The Noninvasive Prenatal Screening Work Group of the American College of Medical Genetics and Genomics","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0175","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1701-2163(15)31025-2","article-title":"Current status in non-invasive prenatal detection of Down Syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma","volume":"35","author":"Langlois","year":"2013","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/bs.acc.2015.12.004_bb0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/IJWH.S67124","article-title":"Non-invasive prenatal testing: a review of international implementation and challenges","volume":"7","author":"Allyse","year":"2015","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/bs.acc.2015.12.004_bb0190","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2353\/ajpath.2006.060161","article-title":"Trophoblastic oxidative stress and the release of cell-free feto-placental DNA","volume":"169","author":"Tjoa","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0195","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/humrep\/deh117","article-title":"Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report","volume":"19","author":"Flori","year":"2004","journal-title":"Hum. Reprod."},{"issue":"Suppl.","key":"10.1016\/bs.acc.2015.12.004_bb0200","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.placenta.2013.11.014","article-title":"Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease","volume":"35","author":"Taglauer","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2015.12.004_bb0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/dmn047","article-title":"The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis","volume":"15","author":"Wright","year":"2009","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/bs.acc.2015.12.004_bb0210","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/1933719115584445","article-title":"Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma","volume":"22","author":"Zhou","year":"2015","journal-title":"Reprod. Sci."},{"key":"10.1016\/bs.acc.2015.12.004_bb0215","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pd.4119","article-title":"Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma","volume":"33","author":"Wang","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pd.4111","article-title":"Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies","volume":"33","author":"Boon","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0225","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1373\/clinchem.2011.165910","article-title":"Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood","volume":"57","author":"Sehnert","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/bs.acc.2015.12.004_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1755-8794-5-57","article-title":"Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies","volume":"5","author":"Jiang","year":"2012","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/bs.acc.2015.12.004_bb0240","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/uog.14792","article-title":"Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146958 pregnancies","volume":"45","author":"Zhang","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000367626","article-title":"Microarray-based cell-free DNA analysis improves noninvasive prenatal testing","volume":"36","author":"Juneau","year":"2014","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/bs.acc.2015.12.004_bb0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajog.2014.08.006","article-title":"Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing","volume":"211","author":"Dar","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0255","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/genes5020310","article-title":"The epigenome view: an effort towards non-invasive prenatal diagnosis","volume":"5","author":"Papageorgiou","year":"2014","journal-title":"Genes (Basel)"},{"key":"10.1016\/bs.acc.2015.12.004_bb0260","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/uog.13460","article-title":"Non-invasive prenatal testing for fetal aneuploidies in the first trimester of pregnancy","volume":"45","author":"Song","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0270","unstructured":"WISECONDOR (WIthin-SamplE COpy Number aberration DetectOR): detect fetal trisomies and smaller CNV's in a maternal plasma sample using whole-genome data, 2015 (29-9-2015)."},{"key":"10.1016\/bs.acc.2015.12.004_bb0275","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","article-title":"Size distributions of maternal and fetal DNA in maternal plasma","volume":"50","author":"Chan","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0285","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pd.4659","article-title":"The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0290","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/pd.4366","article-title":"Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma","volume":"34","author":"Benn","year":"2014","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0295","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.clinbiochem.2015.02.011","article-title":"Cell-free DNA screening for fetal aneuploidy as a clinical service","volume":"48","author":"Cuckle","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0300","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pd.4126","article-title":"The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies","volume":"33","author":"Canick","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0305","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1373\/clinchem.2010.146290","article-title":"Quantification of fetal DNA by use of methylation-based DNA discrimination","volume":"56","author":"Nygren","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks\u2019 gestation: relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0315","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/oby.2012.138","article-title":"Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women","volume":"20","author":"Haghiac","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/bs.acc.2015.12.004_bb0320","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ajog.2012.10.226","article-title":"Maternal plasma DNA sequencing: effects of multiple gestation on aneuploidy detection and the relative cell-free fetal DNA (cff DNA) per fetus","volume":"208","author":"Srinivasan","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0325","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/pd.3892","article-title":"DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations","volume":"32","author":"Canick","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0330","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/jcm3030679","article-title":"Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins","volume":"3","author":"Gromminger","year":"2014","journal-title":"J. Clin. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0335","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1373\/clinchem.2013.207951","article-title":"Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X","volume":"60","author":"Rava","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0340","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/pd.4541","article-title":"Circulating cell free DNA testing: are some test failures informative?","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000337373","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors","volume":"31","author":"Ashoor","year":"2012","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/bs.acc.2015.12.004_bb0350","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/pd.1607","article-title":"Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities?","volume":"27","author":"Gerovassili","year":"2007","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0355","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajog.2004.12.015","article-title":"Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA","volume":"193","author":"Wataganara","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0360","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1373\/clinchem.2010.158030","article-title":"Short-term treadmill running as a model for studying cell-free DNA kinetics in vivo","volume":"57","author":"Beiter","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0365","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/11631380-000000000-00000","article-title":"Circulating cell-free DNA: an up-coming molecular marker in exercise physiology","volume":"42","author":"Breitbach","year":"2012","journal-title":"Sports Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0370","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/pd.4306","article-title":"The cell-free fetal DNA fraction in maternal blood decreases after physical activity","volume":"34","author":"Schlutter","year":"2014","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0375","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.placenta.2014.09.010","article-title":"The effect of exercise and metformin treatment on circulating free DNA in pregnancy","volume":"35","author":"Christiansen","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/bs.acc.2015.12.004_bb0380","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/humrep\/dei165","article-title":"Cell-free fetal DNA levels in pregnancies conceived by IVF","volume":"20","author":"Pan","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2015.12.004_bb0385","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/01.AOG.0000295654.55971.9f","article-title":"Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester","volume":"110","author":"Lapaire","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0390","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humupd\/dmu016","article-title":"The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans","volume":"20","author":"Taylor","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/bs.acc.2015.12.004_bb0395","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0400","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pd.1700","article-title":"Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast","volume":"27","author":"Alberry","year":"2007","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0405","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/humrep\/deg320","article-title":"Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique","volume":"18","author":"Guibert","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/bs.acc.2015.12.004_bb0410","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<801::AID-PD153>3.0.CO;2-E","article-title":"Accuracy of cytogenetic findings on chorionic villus sampling (CVS)\u2014diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986-1992","volume":"17","author":"Hahnemann","year":"1997","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0415","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/jcm3030809","article-title":"Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis","volume":"3","author":"Grati","year":"2014","journal-title":"J. Clin. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molmed.2014.11.010","article-title":"Mosaicism and uniparental disomy in prenatal diagnosis","volume":"21","author":"Eggermann","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0425","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/uog.13277","article-title":"Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center","volume":"43","author":"Lau","year":"2014","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.2409","article-title":"Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction","volume":"30","author":"Robinson","year":"2010","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0435","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/ajmg.a.31389","article-title":"Clinical outcome of infants with confined placental mosaicism and intrauterine growth restriction of unknown cause","volume":"140","author":"Miura","year":"2006","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0440","series-title":"Chromosome Abnormalities and Genetic Counselling","author":"Gardner","year":"2012"},{"key":"10.1016\/bs.acc.2015.12.004_bb0445","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/uog.5133","article-title":"Prenatal testing for uniparental disomy: indications and clinical relevance","volume":"31","author":"Kotzot","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0450","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2013.215145","article-title":"Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing","volume":"60","author":"Wang","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0455","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pd.3946","article-title":"Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X","volume":"32","author":"Yao","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0460","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pd.4160","article-title":"Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population","volume":"33","author":"Song","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0465","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/pd.4076","article-title":"Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service","volume":"33","author":"Lau","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0470","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa1408408","article-title":"Copy-number variation and false positive prenatal aneuploidy screening results","volume":"372","author":"Snyder","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0475","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/nar\/gkt992","article-title":"WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme","volume":"42","author":"Straver","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/bs.acc.2015.12.004_bb0480","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/ejhg.2014.282","article-title":"Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management","volume":"23","author":"Bayindir","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0485","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","article-title":"Coexistence of pregnancy and malignancy","volume":"7","author":"Pavlidis","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/bs.acc.2015.12.004_bb0490","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.4100","article-title":"Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease","volume":"33","author":"Osborne","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0495","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2352-3026(14)00039-8","article-title":"Non-invasive detection of genomic imbalances in Hodgkin\/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study","volume":"2","author":"Vandenberghe","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0500","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamaoncol.2015.1883","article-title":"Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing","volume":"1","author":"Amant","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0505","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1001\/jama.2015.12922","article-title":"Letter to the editor: response to JAMA article noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Sistermans","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/bs.acc.2015.12.004_bb0510","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0515","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/pd.4123","article-title":"Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples","volume":"33","author":"Futch","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0520","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/AOG.0b013e3181c3c938","article-title":"Reliability of fetal sex determination using maternal plasma","volume":"115","author":"Scheffer","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0525","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000322959","article-title":"Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation","volume":"29","author":"Akolekar","year":"2011","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/bs.acc.2015.12.004_bb0530","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/pd.4585","article-title":"Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis","volume":"35","author":"Hill","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0535","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/pd.4593","article-title":"Noninvasive prenatal diagnosis of Huntington disease: detection of the paternally inherited expanded CAG repeat in maternal plasma","volume":"35","author":"van den Oever","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0540","unstructured":"TRIDENT 2014, Trial by Dutch laboratories for Evaluation of Non-Invasive Prenatal Testing (NIPT), 2014 (15-6-2015)."},{"key":"10.1016\/bs.acc.2015.12.004_bb0545","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2393-14-229","article-title":"Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol","volume":"14","author":"Hill","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/bs.acc.2015.12.004_bb0550","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/bmj.39470.643218.94","article-title":"Maximising benefit and minimising harm of screening","volume":"336","author":"Gray","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/bs.acc.2015.12.004_bb0555","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/pd.4139","article-title":"Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis","volume":"33","author":"Benn","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0560","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10897-012-9564-0","article-title":"Noninvasive prenatal testing\/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors","volume":"22","author":"Devers","year":"2013","journal-title":"J. Genet. Couns."},{"key":"10.1016\/bs.acc.2015.12.004_bb0565","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/pd.4666","article-title":"Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective","volume":"35","author":"Sachs","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0575","first-page":"1862","article-title":"Ethical guidelines in genetics and genomics. An Islamic perspective","volume":"26","author":"Al-Aqeel","year":"2005","journal-title":"Saudi Med. J."},{"key":"10.1016\/bs.acc.2015.12.004_bb0580","doi-asserted-by":"crossref","first-page":"231fs15","DOI":"10.1126\/scitranslmed.3008704","article-title":"Noninvasive prenatal testing goes global","volume":"6","author":"Chandrasekharan","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0585","first-page":"416","article-title":"Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia","volume":"53","author":"Hui","year":"2013","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0590","unstructured":"About the PEGASUS project. http:\/\/pegasus-pegase.ca\/pegasus\/2015."},{"key":"10.1016\/bs.acc.2015.12.004_bb0595","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/pd.4637","article-title":"Global perspectives on clinical adoption of NIPT","volume":"35","author":"Minear","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0600","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/pd.4658","article-title":"Reflex antenatal DNA screening for Down syndrome","volume":"35","author":"Wald","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0605","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0969141315581005","article-title":"Performance of antenatal reflex DNA screening for Down's syndrome","volume":"22","author":"Wald","year":"2015","journal-title":"J. Med. Screen."},{"key":"10.1016\/bs.acc.2015.12.004_bb0610","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/ejhg.2015.57","article-title":"Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening","volume":"23","author":"Dondorp","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0615","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/pd.4601","article-title":"Overview of the impact of noninvasive prenatal testing on diagnostic procedures","volume":"35","author":"Warsof","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0620","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/jp.2014.102","article-title":"The utilization of circulating cell-free fetal DNA testing and decrease in invasive diagnostic procedures: an institutional experience","volume":"34","author":"Pettit","year":"2014","journal-title":"J. Perinatol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcu.22243","article-title":"Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection","volume":"43","author":"Wax","year":"2015","journal-title":"J. Clin. Ultrasound"},{"key":"10.1016\/bs.acc.2015.12.004_bb0630","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2014.89","article-title":"Measuring informed choice in population-based reproductive genetic screening: a systematic review","volume":"23","author":"Ames","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0635","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1136\/bmj.a2547","article-title":"Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study","volume":"337","author":"Ekelund","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/bs.acc.2015.12.004_bb0640","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12687-012-0126-9","article-title":"The scope of prenatal diagnosis for women at increased risk for aneuploidies: views and preferences of professionals and potential users","volume":"4","author":"de Jong","year":"2013","journal-title":"J. Community Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0645","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/pd.4579","article-title":"NIPT-based screening for Down syndrome and beyond: what do pregnant women think?","volume":"35","author":"van Schendel","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0650","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ejhg.2014.32","article-title":"Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening","volume":"22","author":"van Schendel","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/bs.acc.2015.12.004_bb0655","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/1471-0528.12579","article-title":"Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake","volume":"121","author":"Lewis","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/bs.acc.2015.12.004_bb0660","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/pd.4697","article-title":"Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals","volume":"35","author":"Tamminga","year":"2015","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0665","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pec.2009.05.014","article-title":"Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals","volume":"78","author":"van den Heuvel","year":"2010","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/bs.acc.2015.12.004_bb0670","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pd.4144","article-title":"Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing","volume":"33","author":"Allyse","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0675","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10897-014-9694-7","article-title":"Attitudes of mothers of children with Down syndrome towards noninvasive prenatal testing","volume":"23","author":"Kellogg","year":"2014","journal-title":"J. Genet. Couns."},{"key":"10.1016\/bs.acc.2015.12.004_bb0680","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/bioe.12126","article-title":"A new ethical landscape of prenatal testing: individualizing choice to serve autonomy and promote public health: a radical proposal","volume":"29","author":"Munthe","year":"2015","journal-title":"Bioethics"},{"key":"10.1016\/bs.acc.2015.12.004_bb0685","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2014.08.028","article-title":"The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis","volume":"182","author":"Beulen","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pd.2919","article-title":"Prenatal detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011","volume":"32","author":"Benn","year":"2012","journal-title":"Prenat. Diagn."},{"key":"10.1016\/bs.acc.2015.12.004_bb0695","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.AOG.0000423819.85283.f4","article-title":"Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy","volume":"120","author":"American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/bs.acc.2015.12.004_bb0700","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMp1304843","article-title":"A new era in noninvasive prenatal testing","volume":"369","author":"Morain","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.acc.2015.12.004_bb0705","unstructured":"Committee Opinion No. 640: cell-free DNA screening for fetal aneuploidy, Obstet. Gynecol. (2015)."},{"key":"10.1016\/bs.acc.2015.12.004_bb0710","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.clinbiochem.2015.03.004","article-title":"Maternal plasma RNA sequencing","volume":"48","author":"Oudejans","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0715","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1073\/pnas.1214046110","article-title":"Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations","volume":"110","author":"Williams","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2015.12.004_bb0720","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.1073\/pnas.1405528111","article-title":"Noninvasive in vivo monitoring of tissue-specific global gene expression in humans","volume":"111","author":"Koh","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2015.12.004_bb0725","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","article-title":"Complementary sequence-mediated exon circularization","volume":"159","author":"Zhang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2015.12.004_bb0730","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1373\/clinchem.2014.221648","article-title":"Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts","volume":"60","author":"Tsui","year":"2014","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.acc.2015.12.004_bb0735","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","article-title":"Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets","volume":"122","author":"Denis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2015.12.004_bb0740","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1182\/blood-2011-03-344408","article-title":"Blood platelets contain tumor-derived RNA biomarkers","volume":"118","author":"Nilsson","year":"2011","journal-title":"Blood"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242315300044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242315300044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:34:37Z","timestamp":1758742477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242315300044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128046890"],"references-count":147,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2015.12.004","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}